Goldman Sachs’s Panacea Acquisition Corp. II Class A Ordinary Shares PANA Stock Holding History

Goldman Sachs’s Portfolio PANA Stock Details PANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-71,700	Closed	-$731K	–	6287
2023 Q1	$731K	Hold	71,700	–	–	﹤0.01%	4606
2022 Q4	$721K	Hold	71,700	–	–	﹤0.01%	4639
2022 Q3	$703K	Hold	71,700	–	–	﹤0.01%	4757
2022 Q2	$700K	Hold	71,700	–	–	﹤0.01%	4860
2022 Q1	$699K	Buy	71,700 +100	+0.1%	+$969	﹤0.01%	5110
2021 Q4	$695K	Hold	71,600	–	–	﹤0.01%	5130
2021 Q3	$700K	Hold	71,600	–	–	﹤0.01%	4995
2021 Q2	$717K	Buy	+71,600	New	+$717K	﹤0.01%	4999

Goldman Sachs's PANA Position: Q2 2023 in Review

Goldman Sachs sold out of Panacea Acquisition Corp. II Class A Ordinary Shares (PANA) in Q2 2023, closing a stake of 71,700 shares — an estimated $731K sold.

Goldman Sachs first reported a position in PANA in Q2 2021 and held it in 8 quarters. The position peaked at $731K in Q1 2023. 0 funds tracked by Wall St. Rank hold PANA as of Q2 2023.

Goldman Sachs reported no remaining Panacea Acquisition Corp. II Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 71,700 Panacea Acquisition Corp. II Class A Ordinary Shares shares in Q2 2023, an estimated $731K.
Goldman Sachs first reported a position in Panacea Acquisition Corp. II Class A Ordinary Shares in Q2 2021 and held it in 8 quarters.
Goldman Sachs's Panacea Acquisition Corp. II Class A Ordinary Shares position peaked at $731K in Q1 2023.
0 funds tracked by Wall St. Rank held Panacea Acquisition Corp. II Class A Ordinary Shares as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.